dr. essel on repeat use of parp inhibitors in ovarian cancer
Published 5 years ago • 176 plays • Length 1:08Download video MP4
Download video MP3
Similar videos
-
6:20
parp inhibitors in recurrent ovarian cancer
-
1:09
dr. zakashansky on repeat exposure to parp inhibitors in patients with ovarian cancer
-
0:58
dr. o’malley on the optimal use of parp inhibitors in advanced ovarian cancer
-
6:25
combinations with parp inhibitors for ovarian cancer
-
1:22
dr. gunderson on the use of parp inhibitors in all-comers with ovarian cancer
-
2:30
dr. matulonis on toxicities with parp inhibitors in ovarian cancer
-
2:32
dr. moore on research evaluating repeat exposure to parp inhibition in ovarian cancer
-
0:56
dr. backes on quality of life with parp inhibitors in ovarian cancer
-
1:25
dr. emens on the combination of checkpoint inhibitors and parp inhibitors in ovarian cancer
-
1:38
dr. chase on niraparib as frontline maintenance therapy in ovarian cancer
-
1:37
dr. konecny on the use of parp inhibitors in patients with ovarian cancer
-
2:18
dr. mirza on efficacy of niraparib/bevacizumab combo in recurrent ovarian cancer
-
2:35
dr. monk on choosing between parp inhibitors in ovarian cancer
-
59:14
parp inhibitors in ovarian cancer: clinical updates from sgo 2023
-
1:18
dr. backes on treatment selection with parp inhibitors in ovarian cancer
-
1:14
dr. copeland on the use of parp inhibitors in ovarian cancer
-
2:23
dr. moore on unanswered questions with parp inhibitors in ovarian cancer
-
1:25
dr. konecny on the indications for parp inhibitors in recurrent ovarian cancer
-
2:22
dr. konecny on the value of parp inhibitors in ovarian cancer